|
| |
|
FRIDAY,
DECEMBER 8, 2000
|
|
09:00-10:00
|
S06:
PLENARY I
Chairperson: F. de Conno, Milan, Italy |
Hall
A |
|
09:00
|
EVIDENCE
BASED PALLIATIVE MEDICINE: WHAT DO WE HAVE AND WHAT DO WE NEED
H.J. McQuay, Oxford, UK |
|
|
09:30
|
EVALUATION
OF PALLIATIVE CARE PROGRAMMES; RESULTS AND METHODOLOGICAL CHALLENGES
S. Kaasa, Trondheim, Norway |
|
|
10:00
|
 Coffee
Break
Sponsored by
BASF PHARMA-KNOLL |
|
| 10:30-12:00 |
S07:
ASSESSMENT OF PAIN AND OTHER SYMPTOMS
Chairpersons: P. Poulain, Villejuife, France
C.J. Furst, Stockholm, Sweden |
Hall
A |
| 10:30 |
RECOMMENDATION
FOR PAIN ASSESSMENT
A. Caraceni, Milan, Italy |
|
| 10:50 |
STANDARDIZED
SYMPTOM ASSESSMENT
J. Pereira, Edmonton, Alberta, Canada |
|
| 11:10 |
QUALITY
OF LIFE IN PALLIATIVE CARE. UNDERSTANDING AND OUTCOMES
S. Kaasa, Trondheim, Norway |
|
| 11:30
Oral
Communication
|
DESCRIPTORS
OF BREATHLESSNESS IN PATIENTS WITH CANCER AND OTHER CARDIORESPIRATORY
DISEASES
A. Wilcock, V. Crosby, A. Hughes, K. Fielding, R. Corcoran, A.E.
Tattersfield, UK |
|
| 11:45
Oral
Communication
|
DOES
COMPREHENSIVE PALLIATIVE CARE IMPROVE HEALTH RELATED QUALITY OF LIFE?
RESULTS FROM A CLUSTER RANDOMISED TRIAL
M. Jordhoy, P. Fayers, J.H. Loge, M. Ahlner-Elmqvist, S. Kaasa,
Trondheim, Norway |
|
| 12:00 |
Lunch
Break, Posters Viewing & Exhibition |
|
| 10:30-12:00 |
S08:
DRUG DEVELOPMENT IN PALLIATIVE CARE: FROM THE LABORATORY TO THE CLINIC
Sponsored by CEPHALON
Chairperson: G. Hanks, Bristol, UK |
Hall
B |
| 10:30
Oral
Communication
|
PRECLINICAL
DEVELOPMENT OF A SPECIFIC TREATMENT FOR BREAKTHROUGH PAIN DESIGN OF THE
NEW ORAL TRANSMUCOSAL APPLICATION FORM OF FENTANYL
D. Coleman, Salt Lake City, UT, USA |
|
| 10:50
Oral
Communication
|
CLINICAL
TRIALS DEVELOPMENT PROGRAMME: INNOVATIVE STUDY DESIGNS
T. King, Salt Lake City, UT, USA |
|
| 11:10
Oral
Communication
|
REGULATORY
ISSUES IN DRUG DEVELOPMENT
A. Clarke, Henley-on-Thames, UK |
|
| 11:30
Oral
Communication
|
EARLY
CLINICAL EXPERIENCE WITH ACTIQ® (OTFC) IN THE USA
J. Cleary, Madison WI, USA |
|
| 11:50 |
Discussion |
|
| 12:00 |
Lunch
Break, Posters Viewing & Exhibition |
|
| 10:30-12:00 |
S09:
HOW TO REVIEW: READING AND EVALUATING SYSTEMATIC REVIEWS
Chairperson: P. Whiffen, Oxford, UK
Systematic reviews are now an increasingly important part of
research but the quality of these reviews are quite variable. The aim of
the session is to cover the difficulties that are commonly found in
reviews and cover the areas of bias that regularly occur in randomised
trials and therefore can be transferred into systematic reviews.
Delegates at the end of a session will understand the importance of
systematic reviews as a means of assessing the evidence around a
particular topic and will gain some ability to critically appraise
systematic reviews. |
Hall
C |
| 10:30 |
HOW
TO READ AND EVALUATE SYSTEMATIC REVIEWS
P. Whiffen, Oxford, UK |
|
| 11:15 |
KEY
ELEMENTS FOR THE PREPARATION OF SYSTEMATIC REVIEWS
H.J. McQuay, Oxford, UK |
|
| 12:00 |
Lunch
Break, Posters Viewing & Exhibition |
|
| 13:00-14:30 |
S10:
NEW ROUTES AND NEW DRUGS IN PAIN MANAGEMENT
Chairpersons: N. Cherny, Jerusalem, Israel
J.A. Ferraz Goncalvez, Porto, Portugal |
Hall
A |
13:00
Oral Communication |
CANNABIS
IN PALLIATIVE CARE
M. Schnelle, Berlin, Germany |
|
| 13:20
Oral
Communication
|
THE
ANALGESIC EFFECT OF PARACETAMOL IN CONCURRENT MORPHINE THERAPY
B. Axelsson, S.B. Christensen, Ostersund, Sweden |
|
| 13:30
Oral
Communication
|
THE
EFFICACY AND TOLERABILITY OF NASAL MORPHINE-CHITOSAN SOLUTION FOR
BREAKTHROUGH CANCER PAIN
H. Pavis, A. Wilcock, J. Edgecombe, D. Carr, C. Manderson, R. Corcoran,
Nottingham, UK |
|
| 13:40
Oral
Communication
|
BUPRENORPHINE
TRANSDERMAL SYSTEM (TDS) (DELIVERY RATES: 35 / 52,5 / 70 MG/H) IN
COMPARISON TO SUBLINGUAL BUPRENORPHINE IN CHRONIC PAIN PATIENTS
K. Boehme, Kassel, Germany |
|
| 13:50
Oral
Communication
|
SAFETY
OF SUBCUTANEOUS CLODRONATE AND EFFICACY IN HYPERCALCEMIA OF MALIGNANCY:
A NOVEL ROUTE OF ADMINISTRATION
C. Roemer-Becuwe, A. Vigano, F. Romano, C. Neumann, J. Hanson, H.K.
Quan, P. Walker, Edmonton, Alberta, Canada |
|
| 14:00
Oral
Communication
|
A
MULTICENTRE UK STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) IN
BREAKTHROUGH PAIN IN CANCER: AN OPEN COMPARISON WITH CONVENTIONAL OPIOID
MEDICATION
G. Hanks, M. Busch, H.M. Burnell-Nugent, UK |
|
| 14:10 |
Discussion |
|
| 13:00-14:30 |
S11:
FREE COMMUNICATIONS - PATIENTS VIEWS AND ATTITUDES
Chairpersons: C.J. Furst, Stockholm, Sweden
J.M. Nunez Olarte, Madrid, Spain |
Hall
B |
| 13:00
Oral
Communication
|
DEVELOPMENT
OF AN EORTC CORE QUESTIONNAIRE FOR ASSESSMENT OF HEALTH-RELATED QUALITY
OF LIFE IN PALLIATIVE CARE
M.A. Groenvold, M.A. Petersen, J. Bjorner, Copenhagen, Denmark |
|
| 13:15
Oral
Communication
|
PALLIATIVE
CARE AT HOME: THE VIEWS OF TERMINALLY ILL PATIENTS AND THEIR CARERS
I. Proot, H. Huijer Abu-Saad, M.J. Smits, G.A.M. Widdershoven,
Maastricht, The Netherlands |
|
| 13:30
Oral
Communication
|
BARRIERS
AND POSSIBILITIES: USING FOCUS GROUPS TO OBTAIN PATIENTS' VIEWS ON
WRITTEN INFORMATION IN PALLIATIVE CARE
S. Payne, S. Large, P. Smith, N. Kubesch, Sheffield, UK |
|
| 13:45
Oral
Communication
|
HEARING
VOICES: ACCESSING ETHICAL INFORMATION RELEVANT TO THE PSYCHOSOCIAL CARE
OF PATIENTS AND FAMILIES
B. Farsides, London, UK |
|
| 14:00
Oral
Communication
|
TERMINALLY
ILL PATIENTS´ ATTITUDES TOWARD EUTHANASIA AND PHYSICIAN-ASSISTED
SUICIDE
S. Johansen, J. Materstvedt, B. Fougner, S. Kaasa, Trondheim, Norway |
|
| 14:15 |
DYING
CANCER PATIENTS EXPERIENCES OF BEING TOUCHED BY NURSES
A. Norman, C. Kjellberg, C.J. Furst, V. Wahlberg, Sweden |
|
| 13:00-14:30 |
S12:
ETHICS IN RESEARCH
Chairperson: K. Foley, New York, USA
D. Clark, Sheffield, UK |
Hall
C |
| 13:00 |
EVALUATION
OF NEEDS FOR PALLIATIVE CARE PATIENTS
K. Heimerl, Vienna, Austria |
|
| 13:30 |
WHERE
ARE THE LIMITS FOR RESEARCH IN PALLIATIVE CARE
D. Clark, Sheffield, UK |
|
| 14:00 |
EPIDEMIOLOGY
OF PAIN - WHAT TRIALS DO WE NEED?
K. Foley, New York, NY, USA |
|
| 14:45-16:15 |
S13:
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
Supported by an unrestricted educational grant from AVENTIS PHARMA
Deutschland GmbH
Chairpersons: G.D. Borasio, Munich, Germany |
Hall
A |
| |
PALLIATIVE
CARE IN ALS: DEFINITION OF THE MODEL SYSTEM
G.D. Borasio, Munich, Germany |
|
| Oral
Communication |
NON-INVASIVE
VENTILATION AS A PALLIATIVE TREATMENT FOR DYSPNEA IN ALS: A PROSPECTIVE
STUDY
V. Querner, O. Karg, C. Neudert, M. Wasner, B. Schlotter, G.D. Borasio,
Munich, Germany |
|
| |
QUALITY
OF LIFE OF HOME-VENTILATED ALS PATIENTS AND THEIR CAREGIVERS: A
CROSS-SECTIONAL STUDY
D. Kaub-Wittemer, N. Von Steinbuechel, M. Wasner, G.D. Borasio, Munich,
Germany |
|
| |
THREE
DIFFERENT APPROACHES TO MEASURING QUALITY OF LIFE IN ALS: A RANDOMISED
TRIAL
C. Neudert, M. Wasner, G.D. Borasio, Greifswald, Germany |
|
| |
SURVEY
ON THE STANDARDS OF PALLIATIVE CARE IN ALS IN EUROPE AND PROPOSALS FOR
FUTURE STUDIES
G.D. Borasio, P.J. Shaw, O. Hardiman, A. Ludolph, M.L. Sales Luis, V.
Silani, Munich, Germany |
|
| 16:15 |
Coffee
Break
Sponsored by JANSSEN-CILAG Germany |
|
| 14:45-16:15 |
S14:
COST EFFECTIVENESS OR QUALITY IMPROVEMENT: DEVELOPING TRIAL DESIGNS
Chairpersons: J. Addington-Hall, London, UK
E. Bruera, Houston, USA |
Hall
B |
| 14:45
Oral
Communication
|
COST-EFFECTIVENESS
IN PALLIATIVE CARE SERVICES
J. Addington-Hall, London, UK |
|
| 15:00 |
QUALITY
STANDARDS FOR PALLIATIVE CARE SERVICES AND HOSPICES
E. Klaschik, Bonn, Germany |
|
| 15:15
Oral
Communication
|
WHY
ARE TRIALS IN PALLIATIVE CARE SO DIFFICULT?
C. Todd, G. Grande, Cambridge, UK |
|
| 15:30
Oral
Communication
|
EVALUATION
OF A HOSPITAL BASED PALLIATIVE CARE SERVICE: RANDOMISED CONTROLLED TRIAL
G. Hanks, D. Sharp, K. Forbes, K. Done, M. Robbins, UK |
|
| 16:15 |
Coffee
Break, Posters Viewing & Exhibition |
|
| 14:45-16:15 |
S15:
CLINICAL RESEARCH IN PALLIATIVE CARE: FUNDING, BASIC TRIAL DESIGN,
RUNNING A STUDY
Chairpersons: G. Hanks, Bristol, UK
P. Thomas, Bexhill-on-sea, UK |
Hall
C |
| 14:45 |
INTRODUCTION
G. Hanks, Bristol, UK |
|
| 14:50 |
APPLYING
FOR RESEARCH FUNDING
R. Hamilton, Bristol, UK |
|
| 15:20 |
BASIC
TRIAL DESIGN
P. Thomas, Bexhill-on-sea, UK |
|
| 15:50 |
GETTING
STARTED
G. Hanks, Bristol, UK |
|
| 16:00 |
THE
ROLE OF THE RESEARCH NURSE
H. Morgan, Bristol, UK |
|
| 16:15 |
Coffee
Break, Posters Viewing & Exhibition |
|
| 16:45-17:45 |
S16:
OPIOIDS SWITCHING-EVALUATION OF A CONCEPT
Moderator: G. Hanks, Bristol, UK |
Hall
A |
| 16:45 |
OPIOIDS
SWITCHING-EVALUATION OF A CONCEPT
E. Bruera, Houston, TX, USA |
|
| 16:50 |
Discussion |
|
| 17:00 |
OPIOIDS
SWITCHING-EVALUATION OF A CONCEPT
N. Cherny, Jerusalem, Israel |
|
| 17:05 |
Discussion |
|
| 17:15 |
OPIOIDS
SWITCHING-EVALUATION OF A CONCEPT
F. Nauck, Bonn, Germany |
|
| 17:20 |
Discussion |
|
| 17:30 |
OPIOIDS
SWITCHING-EVALUATION OF A CONCEPT
G. Hanks, Bristol, UK |
|
| 17:35 |
Discussion |
|
| 18:00-19:30 |
S16B:
GRÜNENTHAL SYMPOSIUM
USE OF MODERN FORMULATIONS IN CHRONIC PAIN PATIENTS
Chairperson: L. Radbruch, Koeln, Germany |
Hall
B |
| 18:00
Oral
Communication
|
PAIN
THERAPY AND QUALITY OF LIFE OF CHRONIC TUMOR PATIENTS
W. Pipam, Klagenfurt, Austria |
|
| 18:15
Oral
Communication
|
PAIN
AND ITS TREATMENT IN CANCER PATIENTS FROM THE POINT OF VIEW OF GENERAL
PRACTITIONERS
H. Janig, Klagenfurt, Austria |
|
| 18:30 |
STRATEGIES
TO MINIMIZE ADVERSE EFFECTS IN THE TREATMENT WITH OPIOIDS
F. de Conno, Milan, Italy |
|
| 18:45
Oral
Communication
|
BUPRENORPHINE
TDS, USE OF MODERN FORMULATIONS IN THE TREATMENT OF CHRONIC PAIN
K. Budd, Bradford, UK |
|
| 19:00
Oral
Communication
|
TREATMENT
OF CANCER PAIN PATIENTS WITH BUPRENOPHINE TDS-CASE STUDIES
R. Likar, Klagenfurt, Austria |
|
| |
 FOLLOWED
BY RECEPTION
Hosted by GRÜNENTHAL |
|
top |
